Difficulty: Easy
Correct Answer: Seems unlikely, but remains a theoretical and low-probability biosafety concern
Explanation:
Introduction / Context:
Horizontal gene transfer (HGT) is the movement of genetic material between organisms outside of parent-to-offspring inheritance. In biotechnology and environmental microbiology, a recurring question is whether engineered antibiotic-resistance markers in laboratory or industrial strains could transfer to pathogens, potentially undermining clinical therapies.
Given Data / Assumptions:
Concept / Approach:
Risk assessment balances plausibility against likelihood. While HGT is biologically possible in principle, well-designed containment, genetic safeguards, and lack of strong selection in the environment make the probability of clinically significant transfer low. Hence, the best answer is that it seems unlikely but remains a theoretical concern, guiding prudent biosafety practices such as markerless constructs or non-clinical resistance markers.
Step-by-Step Solution:
Verification / Alternative check:
Biocontainment strategies (auxotrophies, kill switches) and field monitoring support very low observed transfer rates from engineered strains in controlled applications.
Why Other Options Are Wrong:
Common Pitfalls:
Equating lab demonstration of HGT with real-world, clinically meaningful dissemination; ignoring selection pressure as the key driver.
Final Answer:
Seems unlikely, but remains a theoretical and low-probability biosafety concern
Discussion & Comments